TransAct Technologies Incorporated
NASDAQ:TACTComputer Hardware
+$0.23 today
- Market cap
- $50.07M
- Beta
- 1.27
- P/E (TTM)
- -113.3
- EPS (TTM)
- -$0.05
Volume 0.02M
Average 0.07M
TACT Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
TransAct Technologies IncorporatedNASDAQ: TACT
Gross Margin · Q1 FY2026 · quarter ended Mar 2026
Gross margin widens to 50.3%
Gross margin was 50.3% in Q1 FY2026, up 1.6 pp from a year earlier. On a trailing-twelve-month basis it was 49.0%, up 0.5 pp year over year. Over 3 fiscal years it widened by 6.6 pp.
Context
- Gross margin widened in 1 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 48.6%
- Year-over-year change
- -0.9pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 48.6% | -0.9pp |
| FY2024 | 2024-12-31 | 49.5% | -3.4pp |
| FY2023 | 2023-12-31 | 52.9% | +10.9pp |
| FY2022 | 2022-12-31 | 42.0% | +2.9pp |
| FY2021 | 2021-12-31 | 39.1% | — |
Gross Margin vs competitors
How TACT compares with its peers on the latest reported figures
- TACT's LTM Mar 2026 gross margin of 49.0% is the 2nd highest of the 6 companies compared; the peer median is 29.6%.
- Its year-over-year change of +0.5 pp is the 4th highest of 6, against a peer median of +1.5 pp.
- Over three fiscal years its change of +6.6 pp compares with a peer median of -1.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 86.4% | -0.7 pp | -1.3 pp | |
| LTM Mar 2026 | 49.0% | +0.5 pp | +6.6 pp | |
ODYSOdysight.ai Inc. | LTM Mar 2026 | 34.3% | +1.5 pp | +174.2 pp |
| FY2025 | 29.6% | -17.5 pp | -23.1 pp | |
| LTM Mar 2026 | 14.5% | +18.2 pp | -65.8 pp | |
| FY2025 | 1.7% | +3.1 pp | +46.8 pp | |
| Peer median (excluding TACT) | 29.6% | +1.5 pp | -1.3 pp | |
Competitors are the stored peer set for TACT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 39.39M | 58.14M | 72.63M | 43.38M | 51.48M |
| Cost of Revenue | 24M | 33.73M | 34.23M | 21.9M | 26.47M |
| Gross Profit | 15.38M | 24.41M | 38.4M | 21.48M | 25.02M |
| Gross Margin | 39.1% | 42.0% | 52.9% | 49.5% | 48.6% |
| Research & Development | 7.48M | 8.57M | 9.44M | 6.98M | 6.7M |
| Selling, General & Admin | 17.28M | 23.52M | 23.25M | 18.13M | 19.73M |
| Operating Expenses | 24.76M | 32.09M | 32.69M | 25.11M | 26.43M |
| Depreciation & Amortization | 957K | 1.33M | 1.49M | 1.04M | 672K |
| EBITDA | (4.97M) | (6.36M) | 7.7M | (2.21M) | (73K) |
| EBITDA Margin | -12.6% | -10.9% | 10.6% | -5.1% | -0.1% |
| Operating Income | (9.38M) | (7.68M) | 5.71M | (3.63M) | (1.42M) |
| Operating Margin | -23.8% | -13.2% | 7.9% | -8.4% | -2.7% |
| Interest Income | 61K | 0 | 55K | 469K | 537K |
| Interest Expense | 157K | 208K | 310K | 322K | 339K |
| Other Income / Expenses | 3.29M | (224K) | 197K | 58K | 331K |
| Income Before Tax | (6.08M) | (7.9M) | 5.9M | (3.57M) | (1.08M) |
| Pre-Tax Margin | -15.4% | -13.6% | 8.1% | -8.2% | -2.1% |
| Income Tax Expense | (2.04M) | (1.97M) | 1.16M | 6.3M | 156K |
| Net Income | (4.04M) | (5.94M) | 4.75M | (9.86M) | (1.24M) |
| Net Margin | -10.3% | -10.2% | 6.5% | -22.7% | -2.4% |
| EPS (Basic) | (0.45) | (0.60) | 0.48 | (0.99) | (0.12) |
| EPS (Diluted) | (0.45) | (0.60) | 0.47 | (0.99) | (0.12) |
| Weighted Avg Shares | 9.3M | 9.91M | 9.95M | 10M | 10.09M |
| Weighted Avg Shares (Diluted) | 9.3M | 9.91M | 10.02M | 10M | 10.09M |
TransAct Technologies Incorporated
NASDAQ:TACT
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.